The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents.

导出 LinkOut

翻译打印收藏纠错

作者： Jonathan J,Darrow ^[1] ; Reed F,Beall ^[2] ; Aaron S,Kesselheim ^[2]

作者单位： Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St., Suite 3030, Boston, MA, 02120, USA. jjdarrow@bwh.harvard.edu. ^[1] Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St., Suite 3030, Boston, MA, 02120, USA. ^[2]

主题词制药工业(Drug Industry);药物, 通用名(Drugs, Generic);人类(Humans);立法, 药物(Legislation, Drug);专利(主题)(Patents as Topic);美国(United States)

DOI 10.1007/s40258-018-0420-8

PMID 30141133

发布时间 2020-05-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交